- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Pramlintide Insulin
Total 2852 results
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesNorway, United Kingdom, Sweden, Finland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesBelgium, Luxembourg
-
AstraZenecaCompletedObesity | OverweightUnited States
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesDenmark
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Julphar Gulf Pharmaceutical IndustriesProfil Institut für Stoffwechselforschung GmbHCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Bosnia and Herzegovina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Novo Nordisk A/SCompletedHealthy | DiabetesGermany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesDenmark
-
GeropharmCompletedClamp StudyRussian Federation
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesKorea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIsrael
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited Kingdom, Poland, Spain, India, Argentina, China
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesPoland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Korea, Republic of
-
AstraZenecaCompletedDiabetes Mellitus, Type 1United States
-
Novo Nordisk A/SCompletedHealthy | DiabetesGermany
-
Oregon Health and Science UniversityActive, not recruitingObesityUnited States
-
AstraZenecaCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesNetherlands
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJordan
-
Novo Nordisk A/SCompletedHealthy | DiabetesSouth Africa
-
Novo Nordisk A/SCompletedHealthy | DiabetesUnited States
-
GeropharmCompletedPharmacokinetics | BioequivalenceRussian Federation
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMalaysia, Australia, Taiwan, Thailand, Hong Kong, Singapore, Philippines
-
Novo Nordisk A/SCompleted
-
SanofiTerminatedAMICanada, Brazil, United States, Argentina, Mexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesCanada
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Delivery SystemsIndonesia
-
Novo Nordisk A/SCompletedHealthy | DiabetesSouth Africa
-
University of AarhusCompletedHypoglycemia | Diabetes Mellitus Type IDenmark
-
Novo Nordisk A/SCompletedDiabetes | Type 2 Diabetes MellitusTaiwan, Turkey, India, Algeria, Hong Kong, China, Ukraine
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSlovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesNorway, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTunisia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesPoland, Spain, Sweden, Malaysia, France, Netherlands, India, Argentina, South Africa, Romania, Former Serbia and Montenegro, Austria, Czech Republic, Philippines, Mexico
-
Eli Lilly and CompanyCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
McGill UniversityJuvenile Diabetes Research FoundationCompletedType 1 Diabetes | Type 1 Diabetes Mellitus | Hyperglycemia, PostprandialCanada
-
Novo Nordisk A/SCompletedHealthy | DiabetesJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSouth Africa